A case of pembrolizumab-induced hemophagocytic lymphohistiocytosis successfully treated with pulse glucocorticoid therapy

Treatments using immune checkpoint inhibitors such as pembrolizumab lead to immune mediated adverse effects including hemophagocytic lymphohistiocytosis (HLH). Herein, we present a case where HLH developed after pembrolizumab administration, which was treated using high dose prednisolone. He develop...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Respir Med Case Rep
Main Authors: Takahashi, Hidenori, Koiwa, Tomohiro, Fujita, Akira, Suzuki, Takayuki, Tagashira, Amane, Iwasaki, Yoshinobu
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2020
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7260580/
https://ncbi.nlm.nih.gov/pubmed/32489850
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2020.101097
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados